Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELETRIPTAN HYDROBROMIDE vs ELOTUZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELETRIPTAN HYDROBROMIDE vs ELOTUZUMAB: Safety Overview

Metric ELETRIPTAN HYDROBROMIDE ELOTUZUMAB
Total FAERS Reports 2,158 3,440
Deaths Reported 12 676
Death Rate 0.6% 19.7%
Hospitalizations 271 1,499
Average Patient Age 52.6 yrs 67.6 yrs
% Female Patients 86.2% 41.0%
FDA Approval Date Aug 11, 2017 N/A
Manufacturer Zydus Pharmaceuticals USA Inc. E.R. Squibb & Sons, L.L.C.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription